Inventor · disambiguated record
Matti Davis
Also filed as: DAVIS MATTI
6 granted patents·4 pending applications·18 citations·filing 2001–2022
77Inventor score
Files withAYALA PHARMACEUTICALS INC4BRISTOL MYERS SQUIBB CO1MANNING ANTHONY M1SIGNAL PHARM INC1SIGNAL PHARM LLC1
Top patents by PatentIndex Score
10 records- 0180US6656713B2Compounds and methods for modulating activation of NF-κBSIGNAL PHARM INC·Filed 2001·Granted Dec 2, 2003·14 cites·7 claims
- 0275US7414120B2Compounds and methods for modulating activation of NF-κBSIGNAL PHARMACEUTICALS·Filed 2007·Granted Aug 19, 2008·2 cites·7 claims
- 0364US7186503B2Compounds and methods for modulating activation of NF-κBSIGNAL PHARM LLC·Filed 2003·Granted Mar 6, 2007·2 cites·4 claims
- 0456US8263326B2Compounds and methods for modulating activation of NF-κBMANNING ANTHONY M·Filed 2008·Granted Sep 11, 2012·0 cites·5 claims
- 0554US2023018980A1Bisfluoroalkyl-1,4-benzodiazepinone compounds for treating desmoid tumorsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 0653US2021244745A1Combination compositions comprising bisfluoroalkyl-1,4-benzodiazepinone compounds and methods of use thereofAYALA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 0752US6905836B2Methods for identifying compounds that inhibit ubiquitin-mediated proteolysis of iκbYISSUM RES DEV CO·Filed 2003·Granted Jun 14, 2005·0 cites·54 claims
- 0851US12281085B2Bisfluoroalkyl-1,4-benzodiazepinone compounds and methods of use thereofAYALA PHARMACEUTICALS INC·Filed 2020·Granted Apr 22, 2025·0 cites·10 claims
- 0951US2022339162A1Bisfluoroalkyl-1,4-benzodiazepinone compounds for treating desmoid tumorsAYALA PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1042US2022241294A1Bisfluoroalkyl-1,4-benzodiazepinone compounds for treating notch-activated breast cancerAYALA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matti Davis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →